1-6 of 6
Authors: Marco Metra
Journal Article
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 4, July 2024, Pages 296–306, https://doi.org/10.1093/ehjcvp/pvae026
Published: 17 April 2024
Journal Article
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 2, March 2024, Pages 147–157, https://doi.org/10.1093/ehjcvp/pvad088
Published: 20 November 2023
Journal Article
Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish heart failure registry
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 4, June 2023, Pages 343–352, https://doi.org/10.1093/ehjcvp/pvad012
Published: 30 January 2023
Journal Article
Medical treatment of heart failure with reduced ejection fraction: the dawn of a new era of personalized treatment?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 6, November 2021, Pages 539–546, https://doi.org/10.1093/ehjcvp/pvab033
Published: 26 May 2021
Journal Article
The interplay between cardiology and diabetology: a renewed collaboration to optimize cardiovascular prevention and heart failure management
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 6, November 2020, Pages 394–404, https://doi.org/10.1093/ehjcvp/pvaa051
Published: 13 May 2020
Journal Article
Medical misinformation: vet the message!
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 2, April 2019, Pages 62–63, https://doi.org/10.1093/ehjcvp/pvz001
Published: 28 January 2019
